2018
Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial.
Lester-Coll N, Supko J, Kluytenaar J, Pavlik K, Yu J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Contessa J, Ramani R, Lampert R, Yao X, Bindra R. Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial. Journal Of Clinical Oncology 2018, 36: e14046-e14046. DOI: 10.1200/jco.2018.36.15_suppl.e14046.Peer-Reviewed Original Research
2016
Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion Trial
Lester-Coll N, Kluytenaar J, Pavlik K, Yu J, Contessa J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Ramani R, Lampert R, Yao X, Bindra R. Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion Trial. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s93. DOI: 10.1016/j.ijrobp.2016.06.233.Peer-Reviewed Original Research
2015
ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL
Lester-Coll N, Kluytenaar J, Pavlik K, Yu J, Contessa J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Ramani R, Lampert R, Yao X, Bindra R. ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL. Neuro-Oncology 2015, 17: v13-v13. PMCID: PMC4638537, DOI: 10.1093/neuonc/nov205.15.Peer-Reviewed Original Research